Mitsuru Hashiramoto

2.7k total citations
44 papers, 1.3k citations indexed

About

Mitsuru Hashiramoto is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Mitsuru Hashiramoto has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 19 papers in Surgery and 16 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Mitsuru Hashiramoto's work include Metabolism, Diabetes, and Cancer (22 papers), Pancreatic function and diabetes (18 papers) and Diabetes Treatment and Management (13 papers). Mitsuru Hashiramoto is often cited by papers focused on Metabolism, Diabetes, and Cancer (22 papers), Pancreatic function and diabetes (18 papers) and Diabetes Treatment and Management (13 papers). Mitsuru Hashiramoto collaborates with scholars based in Japan, Australia and United States. Mitsuru Hashiramoto's co-authors include Masato Kasuga, Kohei Kaku, Kazuhito Tawaramoto, David E. James, Masashi Shimoda, Sumiko Hamamoto, Yukiko Kanda, Michihiro Matsuki, Yoshikazu Tamori and Geoffrey D. Holman and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Mitsuru Hashiramoto

44 papers receiving 1.2k citations

Peers

Mitsuru Hashiramoto
Luitgard Mosthaf Germany
Kazuaki Miyake Japan
Jean‐François Decaux France
Pili Zhang United States
Chie Ebato Japan
Cristina Alarcón United States
Mia Klannemark Sweden
Nobuhiro Ban Japan
Andrei I. Oprescu Canada
Søren M. Echwald Denmark
Luitgard Mosthaf Germany
Mitsuru Hashiramoto
Citations per year, relative to Mitsuru Hashiramoto Mitsuru Hashiramoto (= 1×) peers Luitgard Mosthaf

Countries citing papers authored by Mitsuru Hashiramoto

Since Specialization
Citations

This map shows the geographic impact of Mitsuru Hashiramoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuru Hashiramoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuru Hashiramoto more than expected).

Fields of papers citing papers by Mitsuru Hashiramoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsuru Hashiramoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuru Hashiramoto. The network helps show where Mitsuru Hashiramoto may publish in the future.

Co-authorship network of co-authors of Mitsuru Hashiramoto

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuru Hashiramoto. A scholar is included among the top collaborators of Mitsuru Hashiramoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuru Hashiramoto. Mitsuru Hashiramoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hirukawa, Hidenori, Hideaki Kaneto, Masashi Shimoda, et al.. (2015). Combination of DPP-4 inhibitor and PPARγ agonist exerts protective effects on pancreatic β-cells in diabetic db/db mice through the augmentation of IRS-2 expression. Molecular and Cellular Endocrinology. 413. 49–60. 19 indexed citations
2.
Tawaramoto, Kazuhito, Hideaki Kaneto, Mitsuru Hashiramoto, et al.. (2015). Azelnidipine, but not amlodipine, reduces urinary albumin excretion and carotid atherosclerosis in subjects with type 2 diabetes: blood pressure control with olmesartan and azelnidipine in Type 2 diabetes (BOAT2 study). Diabetology & Metabolic Syndrome. 7(1). 80–80. 9 indexed citations
3.
Kanda, Yukiko, Mitsuru Hashiramoto, Masashi Shimoda, et al.. (2014). Dietary restriction preserves the mass and function of pancreatic β cells via cell kinetic regulation and suppression of oxidative/ER stress in diabetic mice. The Journal of Nutritional Biochemistry. 26(3). 219–226. 27 indexed citations
4.
Anno, Takatoshi, Mitsuru Hashiramoto, Akihito Tanabe, et al.. (2013). A Case of Type 2 Diabetes Mellitus Associated with a Drug-Induced Fever Caused by a DPP-4 Inhibitor, Sitagliptin. 56(5). 292–297. 1 indexed citations
5.
Tatsumi, Fuminori, Mitsuru Hashiramoto, Hidenori Hirukawa, et al.. (2013). Concomitant use of miglitol and mitiglinide as initial combination therapy in type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 101(1). 35–44. 10 indexed citations
6.
Hamamoto, Sumiko, Yukiko Kanda, Masashi Shimoda, et al.. (2012). Vildagliptin preserves the mass and function of pancreatic β cells via the developmental regulation and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes. Diabetes Obesity and Metabolism. 15(2). 153–163. 55 indexed citations
7.
Hashiramoto, Mitsuru & Kohei Kaku. (2012). Sirtuin 1 as a key player of ‘metabolic memory’. Journal of Diabetes Investigation. 4(1). 34–36. 2 indexed citations
8.
Kaku, Kohei & Mitsuru Hashiramoto. (2011). Thiazolidinediones and bone fractures. Journal of Diabetes Investigation. 2(5). 354–355. 5 indexed citations
9.
10.
Ogawa, Wataru, Kazuya Iwamoto, Hiroyuki Mori, et al.. (2009). Two related cases of type A insulin resistance with compound heterozygous mutations of the insulin receptor gene. Diabetes Research and Clinical Practice. 83(3). e75–e77. 5 indexed citations
11.
Kanda, Yukiko, Masashi Shimoda, Kazuhito Tawaramoto, et al.. (2009). Molecular Analysis of db Gene-related Pancreatic .BETA. Cell Dysfunction; Evidence for a Compensatory Mechanism Inhibiting Development of Diabetes in the db Gene Heterozygote. Endocrine Journal. 56(8). 997–1008. 10 indexed citations
12.
Kanda, Yukiko, Masafumi Matsuda, Kazuhito Tawaramoto, et al.. (2008). Effects of sulfonylurea drugs on adiponectin production from 3T3-L1 adipocytes: Implication of different mechanism from pioglitazone. Diabetes Research and Clinical Practice. 81(1). 13–18. 22 indexed citations
13.
Osawa, Haruhiko, Kazuya Yamada, Hiroshi Onuma, et al.. (2004). The G/G Genotype of a Resistin Single-Nucleotide Polymorphism at −420 Increases Type 2 Diabetes Mellitus Susceptibility by Inducing Promoter Activity through Specific Binding of Sp1/3. The American Journal of Human Genetics. 75(4). 678–686. 199 indexed citations
14.
Iwamoto, Kazuya, Hiroyuki Mori, Hideki Okazawa, Mitsuru Hashiramoto, & Masato Kasuga. (2002). Identification of a single nucleotide polymorphism showing no insulin-mediated suppression of the promoter activity in the human insulin receptor substrate 2 gene. Diabetologia. 45(8). 1182–1195. 6 indexed citations
15.
Mori, Hiroyuki, Hideki Okazawa, Kazuya Iwamoto, et al.. (2001). A polymorphism in the 5' untranslated region and a Met 229 ? Leu variant in exon 5 of the human UCP1 gene are associated with susceptibility to Type II diabetes mellitus. Diabetologia. 44(3). 373–376. 29 indexed citations
16.
Kotani, Ko, et al.. (2000). Inhibition of Insulin-induced Glucose Uptake by Atypical Protein Kinase C Isotype-specific Interacting Protein in 3T3-L1 Adipocytes. Journal of Biological Chemistry. 275(34). 26390–26395. 30 indexed citations
17.
Hashiramoto, Mitsuru & David E. James. (1998). SNAREing GLUT4 at the Plasma Membrane in Muscle and Fat. Advances in experimental medicine and biology. 441. 47–61. 6 indexed citations
18.
Tamori, Yoshikazu, Mitsuru Hashiramoto, Satoshi Araki, et al.. (1996). Cleavage of Vesicle-Associated Membrane Protein (VAMP)-2 and Cellubrevin on GLUT4-Containing Vesicles Inhibits the Translocation of GLUT4 in 3T3-L1 Adipocytes. Biochemical and Biophysical Research Communications. 220(3). 740–745. 59 indexed citations
19.
Yoshida, Reiko, Toshiki Hozumi, Hiroshi Ueno, et al.. (1995). Hypertrophic Cardiomyopathy in Patients with Diabetes Mellitus Associated with Mitochondrial tRNALeu(UUR) Gene Mutation.. Internal Medicine. 34(10). 953–958. 2 indexed citations
20.
UEDA, Hiroo, Manabu Ogura, Kazuaki Miyamoto, et al.. (1993). Importance of serum cholesterol level in development of diabetic autonomic neuropathy. Diabetes Research and Clinical Practice. 21(2-3). 123–126. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luitgard Mosthaf Breakdown of academic impact, for papers by Kazuaki Miyake Breakdown of academic impact, for papers by Jean‐François Decaux Breakdown of academic impact, for papers by Pili Zhang Breakdown of academic impact, for papers by Chie Ebato Breakdown of academic impact, for papers by Cristina Alarcón Breakdown of academic impact, for papers by Mia Klannemark Breakdown of academic impact, for papers by Nobuhiro Ban Breakdown of academic impact, for papers by Andrei I. Oprescu Breakdown of academic impact, for papers by Søren M. Echwald
Rankless by CCL
2026